Congress: Target the Middlemen Who Drive Up Drug Costs
David Balto authored an opinion in Healthcare Dive on why Congress should target PBMs, the middlemen, that drive up drugs costs. See the...
Consumer Groups Ask FTC to Implement Rules Against Pharma Rebate Walls
Families USA, SEIU, AFSCME, Public Interest Research Group, Consumer Action, Alliance for Retired Americans, Doctors for America,...
FTC’s current approach to pharmaceutical merger enforcement is too lax.
On June 25, 2021, Consumer groups and unions including Families USA, Public Interest Research Group, Services Employees International...
Consumer Groups Submit Letter to Chairwoman Maloney Thanking Her For Her Work on AbbVie
On June 16, 2021, Consumer Groups and unions including American Federation of State, County, and Municipal Employees, Alliance for...
Secretary of HHS Becerra May Play Large Role In Combatting Rebate Walls.
The following article focuses on anti-competitive practices, and the role Secretary of HHS Becerra may play in addressing this issue....
Consumer Groups Recommend Increased Enforcement Against Pharmaceutical Rebate Walls
On February 18, 2021, Consumer Action and U.S. Public Interest Research Group submitted recommendations to the Biden/Harris Transition...
Consumer Groups and Unions Submit Letter in Support of PBM Bill Lowering Drug Prices
Yesterday, December 16th, a number of consumer groups and unions submitted a letter in support of H.R. 5304, a bill to regulate pharmacy...
House of Representatives Passes Bill Allowing Medicare to Negotiate For Lower Drug Prices
Yesterday, on Thursday, December 12th, the House of Representatives passed HR 3, Speaker Nancy Pelosi's bill to lower prescription drug...
Panel Examines Patent Abuse and How It Contributes to Rising Drug Prices
This morning, the Bipartisan Policy Center held a forum called "Examining Pharmaceutical Patent Practices & Their Impact on Drug Prices."...
Massachusetts Senate Passes Bill to Regulate PBMs
Recently the Massachusetts Senate, spurred by rising drug prices and federal inaction, passed a sweeping bill to reduce prescription drug...
